← 返回

一种 GAPDH 血清素化系统将 CD8(+) T 细胞糖酵解代谢与抗肿瘤免疫偶联

英文原题:A GAPDH serotonylation system couples CD8(+) T cell glycolytic metabolism to antitumor immunity.

查看英文原题

A GAPDH serotonylation system couples CD8(+) T cell glycolytic metabolism to antitumor immunity.

PubMed 2024/01/11(内容时间) Mol Cell Q1 · IF 16(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

除了经典的5-羟色胺(5-hydroxytryptamine [5-HT])受体信号转导模式外,近期还注意到5-HT参与的翻译后血清素化修饰。

在此,我们报道了一种甘油醛-3-磷酸脱氢酶(GAPDH)血清素化系统,该系统促进CD8+ T细胞的糖酵解代谢和抗肿瘤免疫活性。组织转谷氨酰胺酶2(TGM2)将5-HT转移至GAPDH谷氨酰胺262位点并催化血清素化反应。血清素化支持GAPDH的细胞质定位,从而诱导CD8+ T细胞发生糖酵解代谢转变,并有助于抗肿瘤免疫。CD8+ T细胞通过色氨酸羟化酶1(TPH1)合成以及通过5-羟色胺转运体(SERT)从细胞外摄取两种途径积累细胞内5-HT以进行血清素化。单胺氧化酶A(MAOA)降解5-HT,并作为CD8+ T细胞的内在负调控因子。过继转移产生5-HT的TPH1过表达CAR-T(CAR-T)细胞诱导了强大的抗肿瘤反应。

我们的发现通过提供不依赖受体的血清素化翻译后修饰的证据,扩展了已知的神经免疫相互作用模式范围。

展开英文摘要原文

Apart from the canonical serotonin (5-hydroxytryptamine [5-HT])-receptor signaling transduction pattern, 5-HT-involved post-translational serotonylation has recently been noted.

Here, we report a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) serotonylation system that promotes the glycolytic metabolism and antitumor immune activity of CD8 + T cells. Tissue transglutaminase 2 (TGM2) transfers 5-HT to GAPDH glutamine 262 and catalyzes the serotonylation reaction. Serotonylation supports the cytoplasmic localization of GAPDH, which induces a glycolytic metabolic shift in CD8 + T cells and contributes to antitumor immunity.

CD8 + T cells accumulate intracellular 5-HT for serotonylation through both synthesis by tryptophan hydroxylase 1 (TPH1) and uptake from the extracellular compartment via serotonin transporter (SERT). Monoamine oxidase A (MAOA) degrades 5-HT and acts as an intrinsic negative regulator of CD8 + T cells. The adoptive transfer of 5-HT-producing TPH1-overexpressing chimeric antigen receptor T (CAR-T) cells induced a robust antitumor response.

Our findings expand the known range of neuroimmune interaction patterns by providing evidence of receptor-independent serotonylation post-translational modification.

论文信息

作者
Wang X、Fu SQ、Yuan X、Yu F、Ji Q、Tang HW、Li RK、Huang S
第一作者单位
Department of Radiation Oncology, Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, P.R. China. Electronic address: jsdxwx@126.com.China
通讯作者单位
State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, P.R. China. Electronic address: zzhang@shsci.org.China
文献类型
非美国政府资助研究
期刊
Molecular cell2024 Feb 15
原文标识
PubMed 38215751 · DOI 10.1016/j.molcel.2023.12.015